CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
California State University San Marcos Corporation |
Dr. Bianca Romina Mothé |
COMPASS Training Grant |
COMPASS Program for Southern California Hispanic Serving Institution |
$2,769,800 |
The University Corporation at California State University, Northridge |
Dr. Cindy S Malone |
COMPASS Training Grant |
CSUN CIRM COMPASS Training Program (N-COMPASS) |
$2,680,805 |
Cal State Univ, San Bernadino |
Daniel Nickerson |
COMPASS Training Grant |
Student Pluripotency: Realizing Untapped Undergraduate Potential in Regenerative Medicine |
$2,901,853 |
Cal State Fullerton |
Alison Miyamoto |
COMPASS Training Grant |
COMPASS: an inclusive Pipeline for Research and Other Stem cell-based Professions in Regenerative medicine (iPROSPR) |
$2,760,385 |
University of California, Irvine |
Dr. Brian J. Cummings |
COMPASS Training Grant |
Research Mentorship Program in Regenerative Medicine Careers for a Diverse Undergraduate Student Body |
$2,713,400 |
The Regents of the University of California on behalf of its Riverside Campus |
Dr. Huinan Hannah Liu |
COMPASS Training Grant |
Research Training and Mentorship Program to Inspire Diverse Undergraduates toward Regenerative Medicine Careers (RAMP) |
$2,910,000 |
University of California, Davis |
Dr. Alice F Tarantal |
COMPASS Training Grant |
COMPASS Undergraduate Program |
$2,909,950 |
MiraCosta College |
Dr. Michael Fino |
COMPASS Training Grant |
Increase Diversity, Equity, and Advancement in Cell Based Manufacturing Sciences (IDEA-CBMS) |
$2,878,000 |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Dr. Virender K. Rehan M.D. |
Research Training Grant |
Stem Cell Training Program at the Lundquist Institute |
$5,349,109 |
University of California, Irvine |
Dr. Peter J Donovan |
Research Training Grant |
CIRM Scholars Comprehensive Research Training Program |
$5,373,742 |
University of California, Santa Barbara |
Dr. Dennis O. Clegg Dr. |
Research Training Grant |
CIRM Training Program in Stem Cell Biology and Engineering |
$2,298,239 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Evan Y. Snyder |
Research Training Grant |
A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network |
$5,289,413 |
University of California, San Francisco |
Dr. Robert Blelloch MD, PHD. |
Research Training Grant |
Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research |
$5,373,742 |
Calibr |
Peter G. Schultz |
Research Training Grant |
Training Scholars in Regenerative Medicine and Stem Cell Research |
$5,304,759 |
University of California, San Diego |
Professor Alysson R Muotri |
Research Training Grant |
Interdisciplinary Stem Cell Training Grant at UCSD III |
$5,366,188 |
Children’s Hospital of Los Angeles |
Dr Ching-Ling Lien Ph.D. |
Research Training Grant |
CIRM Training Program for Stem Cell and Regenerative Medicine Research |
$5,373,242 |
University of California, Davis |
Dr Jan A Nolta |
Research Training Grant |
CIRM Cell and Gene Therapy Training Program 2.0 |
$5,013,550 |
University of California, Berkeley |
Dirk Hockemeyer |
Research Training Grant |
Training the Next Generation of Biologists and Engineers for Regenerative Medicine |
$5,327,980 |
Stanford University |
Tushar Desai |
Research Training Grant |
CIRM Scholar Training Program |
$5,347,815 |
City of Hope, Beckman Research Institute |
Dr. Michael E. Barish Ph, D. |
Research Training Grant |
Research Training Program in Stem Cell Biology and Regenerative Medicine |
$5,234,731 |
Gladstone Institutes, J. David |
Dr. Bruce R. Conklin |
Research Training Grant |
CIRM Regenerative Medicine Research Training Program |
$5,373,742 |
University of California, Santa Cruz |
Dr. Camilla Forsberg |
Research Training Grant |
CIRM Training Program in Systems Biology of Stem Cells |
$5,278,566 |
University of Southern California |
Dr. Francesca Mariani |
Research Training Grant |
Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine |
$5,373,742 |
University of California, Los Angeles |
William Lowry |
Research Training Grant |
UCLA Training Program in Stem Cell Biology |
$5,373,742 |
The Regents of the University of California on behalf of its Riverside Campus |
Dr. Prue Talbot |
Research Training Grant |
TRANSCEND – Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity |
$5,344,306 |
Cedars-Sinai Medical Center |
Cedars-Sinai Medical Center Wafa Tawackoli |
Research Training Grant |
CIRM Training Program in Translational Regenerative Medicine |
$5,373,075 |
University of California, San Diego |
Dr. Steven F Dowdy |
Discovery Research Projects |
Development of Anti-COVID RNAi Therapeutics Using Human iPSC-Derived Alveolar Epithelial Cells |
$150,000 |
Celularity Inc. |
William van der Touw |
Clinical Trial Stage Projects |
A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 |
$315,000 |
University of California, San Francisco |
Dr. Michael Matthay MD |
Clinical Trial Stage Projects |
Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative) |
$699,798 |
City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Clinical Trial Stage Projects |
Evaluation and Characterization of SARS-CoV-2 Antibody in Convalescent Volunteer Plasma Donors for Potential Therapeutic Use |
$999,999 |
University of California, Los Angeles |
Dr. Vaithilingaraja Arumugaswami PhD |
Therapeutic Translational Research Projects |
COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage |
$349,999 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Evan Y. Snyder |
Discovery Research Projects |
Using hiPSC-derived lung organoids, a clinically-relevant system, to validate & winnow a list of approved drugs that inhibit SARS-CoV-2 cytopathy |
$219,006 |
University of California, Los Angeles |
Dr. Lili Yang |
Discovery Research Projects |
Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells |
$250,000 |
University of Southern California |
Preet M Chaudhary |
Discovery Research Projects |
Chimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2 |
$248,125 |
University of California, San Diego |
Dr Karen Christman |
Discovery Research Projects |
Pro-healing biomaterial for treating lung inflammation associated with COVID-19 |
$221,758 |
City of Hope, Beckman Research Institute |
Dr Jianhua Yu |
Discovery Research Projects |
Persistent Off-the-Shelf meACE2-CAR-IL-15 NK Cells Derived from CD34(+) Cord Blood Stem Cells to Prevent and Treat COVID-19 |
$150,000 |
Stanford University |
Dr. Albert J Wong |
Discovery Research Projects |
Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2 |
$249,999 |
Stanford University |
Professor Helen M. Blau PhD |
Discovery Research Projects |
Application of PGE2/BPV, a muscle stem cell targeting therapeutic, to the treatment of COVID-19 associated diaphragm atrophy |
$149,996 |
University of Southern California |
Dr. Justin K Ichida |
Discovery Research Projects |
Development of a novel PIKFYVE kinase inhibitor for the treatment of COVID-19 |
$140,067 |
University of California, Los Angeles |
Prof. Song Li |
Discovery Research Projects |
Biomaterial vaccine to enhance the formation of SARS-CoV-2-specific T memory stem cells |
$149,916 |
University of California, Los Angeles |
UCLA Gay M Crooks |
Discovery Research Projects |
Stem cell-based rapid identification of SARS-CoV-2 T cell epitopes and T cell receptors for therapeutic use |
$126,692 |
Calibr |
Stuart A Lipton |
Discovery Research Projects |
Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage |
$150,000 |
University of California, Los Angeles |
Dr. Brigitte Gomperts |
Discovery Research Projects |
Identifying a lead compound for COVID19 using high throughput screening with lung stem cell organoids |
$149,998 |
University of California, Irvine |
Daniela A. Bota |
Conference – The 2020 Grantee Meeting |
2020 CIRM Grantee Meeting |
$176,762 |
University of California, Irvine |
Daniela A. Bota |
Conference – The Alpha Stem Cell Clinic Annual Symposium |
2023 Alpha Stem Cell Clinic Annual Symposium |
$49,512 |
University of California, Davis |
Dr Mehrdad Abedi |
Conference – The Alpha Stem Cell Clinic Annual Symposium |
CIRM – Leading the New Era of Living Medicines |
$6,738 |
Boston Children’s Hospital |
David Williams |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease |
$8,333,581 |
University of California, San Francisco |
Mark C. Walters M.D. |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease |
$8,389,407 |
ExCellThera Inc. |
Dr Pierre Caudrelier |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
A Phase 1 Study of ECT-001 Expanded Cord Blood and Myeloablative Regimen with Reduced Toxicity in Patients with Severe Sickle Cell Disease. |
$600,000 |
University of California, San Francisco |
Mark C. Walters M.D. |
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium |
2019 Alpha Stem Cell Clinic Symposium – Mending Stem Cells: The Past, Present & Future Regenerative Medicine |
$60,000 |